Clinical Trials List
2025-09-16 - 2031-12-31
Phase II
Recruiting7
ICD-10M08.1
Juvenile ankylosing spondylitis
ICD-10M45.0
Ankylosing spondylitis of multiple sites in spine
ICD-10M45.1
Ankylosing spondylitis of occipito-atlanto-axial region
ICD-10M45.2
Ankylosing spondylitis of cervical region
ICD-10M45.3
Ankylosing spondylitis of cervicothoracic region
ICD-10M45.4
Ankylosing spondylitis of thoracic region
ICD-10M45.5
Ankylosing spondylitis of thoracolumbar region
ICD-10M45.6
Ankylosing spondylitis lumbar region
ICD-10M45.7
Ankylosing spondylitis of lumbosacral region
ICD-10M45.8
Ankylosing spondylitis sacral and sacrococcygeal region
ICD-10M45.9
Ankylosing spondylitis of unspecified sites in spine
ICD-10M48.8X1
Other specified spondylopathies, occipito-atlanto-axial region
ICD-10M48.8X2
Other specified spondylopathies, cervical region
ICD-10M48.8X3
Other specified spondylopathies, cervicothoracic region
ICD-10M48.8X4
Other specified spondylopathies, thoracic region
ICD-10M48.8X5
Other specified spondylopathies, thoracolumbar region
ICD-10M48.8X6
Other specified spondylopathies, lumbar region
ICD-10M48.8X7
Other specified spondylopathies, lumbosacral region
ICD-10M48.8X8
Other specified spondylopathies, sacral and sacrococcygeal region
ICD-10M48.8X9
Other specified spondylopathies, site unspecified
ICD-9720.0
Ankylosing spondylitis
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 蔡弘正 Division of Rheumatology
- C. D. CHOU Division of Rheumatology
- Wei-Sheng Chen Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
315 participants
